Keyphrases
Risk Factors
100%
Patients with Hematological Malignancies
100%
Acute Kidney Injury
100%
High-dose Methotrexate (HD-MTX)
100%
At-risk
14%
Age at Diagnosis
14%
Consecutive Patients
14%
Mortality Rate
14%
Logistic Regression Model
14%
Increased Mortality
14%
Confidence Interval
14%
Adverse Events
14%
Oncology Patients
14%
Lymphoma
14%
Albumin Level
14%
Albumin
14%
Acute Lymphoblastic Leukemia
14%
Drug Administration
14%
Univariate Analysis
14%
Baseline Variables
14%
Overall Survival
14%
Kaplan-Meier Method
14%
Log-rank Test
14%
Creatinine Level
14%
Strong Factors
14%
Primary Central Nervous System Lymphoma (PCNSL)
14%
Renal Toxicity
14%
Central Nervous System Prophylaxis
14%
Nursing and Health Professions
Drug Megadose
100%
Acute Kidney Failure
100%
Hematologic Malignancy
100%
Methotrexate
100%
Logistic Regression Analysis
14%
Mortality Rate
14%
Confidence Interval
14%
Adverse Event
14%
Albumin Level
14%
Univariate Analysis
14%
Overall Survival
14%
Creatinine
14%
Lactate Dehydrogenase
14%
Log Rank Test
14%
Nephrotoxicity
14%
Kaplan Meier Method
14%
Acute Lymphoblastic Leukemia
14%
Drug Administration
14%
Primary Central Nervous System Lymphoma
14%
Medicine and Dentistry
Methotrexate
100%
Drug Megadose
100%
Hematologic Malignancy
100%
Acute Kidney Injury
100%
Logistic Regression Analysis
14%
Mortality Rate
14%
Adverse Event
14%
Oncology
14%
Acute Lymphoblastic Leukemia
14%
Creatinine
14%
Univariate Analysis
14%
Central Nervous System
14%
Overall Survival
14%
Kaplan Meier Method
14%
Lactate Dehydrogenase
14%
Drug Administration
14%
Log Rank Test
14%
Nephrotoxicity
14%
Primary Central Nervous System Lymphoma
14%
Pharmacology, Toxicology and Pharmaceutical Science
Methotrexate
100%
Hematologic Malignancy
100%
Acute Kidney Failure
100%
Mortality Rate
14%
Adverse Event
14%
Drug Administration
14%
Acute Lymphoblastic Leukemia
14%
Creatinine
14%
Overall Survival
14%
Lactate Dehydrogenase
14%
Nephrotoxicity
14%
Primary Central Nervous System Lymphoma
14%